Study of atazanavir-induced hyperbilirubinemia among HIV patients on second-line anti-retroviral therapy
Author(s) -
GN Devamsh,
K. V. Ravi,
KJ Umesh,
B. C. Prashant
Publication year - 2020
Publication title -
apik journal of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 2666-1810
pISSN - 2666-1802
DOI - 10.4103/ajim.ajim_32_19
Subject(s) - atazanavir , ritonavir , regimen , medicine , discontinuation , protease inhibitor (pharmacology) , population , dosing , pharmacology , antiretroviral therapy , human immunodeficiency virus (hiv) , viral load , immunology , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom